Sign in
Active, not recruitingNo phase

Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)

Key facts

Who runs it
Hospital Universitari Vall d'Hebron Research Institute
Where
Spain7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
224 people, planned
Started
9 Jul 2018
Expected to end
Dec 2026
Type of study
Observational
Record updated
29 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Patients aged 18 years or older with repaired tetralogy of Fallot or double outlet right ventricle Fallot type

Who cannot take part

  • Patients with pathologies that affect collagen metabolism (liver cirrhosis, stage ≥4 renal insufficiency, pulmonary fibrosis, metabolic bone disease, connective tissue diseases, active neoplasms, active treatment with corticosteroids and bone fractures or surgery in the previous 6 months)
  • Patients with pathologies that may interfere with the determination of the extracellular volume of myocardium (ischemic heart disease, storage diseases)
  • Pregnancy
  • Denial of informed consent
  • Patients with claustrophobia and pacemakers or defibrillators

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to study the correlation between biomarkers of myocardial fibrosis (extracellular volume fraction calculated by cardiac magnetic resonance imaging (MRI) (T1-mapping) and levels of molecular biomarkers of fibrosis) and adverse events in a population of patients with repaired tetralogy of Fallot.

The group in the trial

  • Patients

    Patients with Tetralogy of Fallot

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Interstitial Myocardial Fibrosis in Repaired Tetralogy of Fallot: Assessment by Molecular and Imaging Biomarkers and Association With Adverse Events ( Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
Record updated
29 April 2026